Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy.

Damiani G, Federico B, Silvestrini G, Bianchi CB, Anselmi A, Iodice L, Ronconi A, Navarra P, Da Cas R, Raschetti R, Ricciardi W.

Eur J Clin Pharmacol. 2013 Apr;69(4):957-63. doi: 10.1007/s00228-012-1422-3. Epub 2012 Oct 23.

PMID:
23090700
2.

The impact of regional co-payment and national reimbursement criteria on statins use in Italy: an interrupted time-series analysis.

Damiani G, Federico B, Anselmi A, Bianchi CB, Silvestrini G, Iodice L, Navarra P, Da Cas R, Raschetti R, Ricciardi W.

BMC Health Serv Res. 2014 Jan 6;14:6. doi: 10.1186/1472-6963-14-6.

3.

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Klepser DG, Huether JR, Handke LJ, Williams CE.

J Manag Care Pharm. 2007 Nov-Dec;13(9):765-77.

5.

Antidepressant utilization in primary care in a Spanish region: impact of generic and reference-based pricing policy (2000-2004).

Ubeda A, Cardo E, Sellés N, Broseta R, Trillo JL, Fernández-Llimós F.

Soc Psychiatry Psychiatr Epidemiol. 2007 Mar;42(3):181-8. Epub 2007 Jan 17.

PMID:
17235443
6.

The effect of a Medicaid drug copayment program on the utilization and cost of prescription services.

Nelson AA Jr, Reeder CE, Dickson WM.

Med Care. 1984 Aug;22(8):724-36.

PMID:
6433121
7.

The effects of new pricing and copayment schemes for pharmaceuticals in South Korea.

Lee IH, Bloor K, Hewitt C, Maynard A.

Health Policy. 2012 Jan;104(1):40-9. doi: 10.1016/j.healthpol.2011.09.003. Epub 2011 Oct 14.

PMID:
22000599
8.

Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates.

Barbui C, Campomori A, D'Avanzo B, Negri E, Garattini S.

Soc Psychiatry Psychiatr Epidemiol. 1999 Mar;34(3):152-6.

PMID:
10327841
9.

Adoption of new antiglaucoma drugs in Finland: impact of changes in copayment.

Martikainen JE, Häkkinen U, Enlund H.

Clin Ther. 2007 Nov;29(11):2468-76.

PMID:
18158088
10.

The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors.

Wang J, White-Means SI, Hufstader MA, Walker GD.

Curr Med Res Opin. 2007 Apr;23(4):853-63.

PMID:
17407642
11.

Unintended consequences of a Medicaid prescription copayment policy.

Lieberman DA, Polinski JM, Choudhry NK, Avorn J, Fischer MA.

Med Care. 2014 May;52(5):422-7. doi: 10.1097/MLR.0000000000000119.

PMID:
24686394
12.

Cost containment interventions introduced on the community drugs schemes in Ireland-evaluation of expenditure trends using a national prescription claims database.

Usher C, Tilson L, Bennett K, Barry M.

Clin Ther. 2012 Mar;34(3):632-9. doi: 10.1016/j.clinthera.2012.01.025. Epub 2012 Mar 3.

PMID:
22381716
13.

Are we going to increase the use of antidepressants up to that of benzodiazepines?

Ciuna A, Andretta M, Corbari L, Levi D, Mirandola M, Sorio A, Barbui C.

Eur J Clin Pharmacol. 2004 Nov;60(9):629-34. Epub 2004 Sep 23.

PMID:
15448956
14.

Pharmaceutical cost-containment policy: experiences in Shanghai, China.

Hu S, Chen W, Cheng X, Chen K, Zhou H, Wang L.

Health Policy Plan. 2001 Dec;16 Suppl 2:4-9.

PMID:
11772985
15.

Recent trends in drug utilization in Israel.

Sax P.

Isr J Med Sci. 1992 Oct;28(10):718-25.

PMID:
1399502
16.

An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.

Berndt ER, Bhattacharjya A, Mishol DN, Arcelus A, Lasky T.

J Ment Health Policy Econ. 2002 Mar;5(1):3-19.

PMID:
12529566
17.

Trends in the consumption of antidepressant drugs in Lithuania in 2002-2004.

Kadusevicius E, Mikucionyte L, Maciulaitis R, Milvidaite I, Sveikata A.

Medicina (Kaunas). 2006;42(12):1020-9.

18.

Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.

Andersson K, Bergström G, Petzold MG, Carlsten A.

Health Policy. 2007 May;81(2-3):376-84. Epub 2006 Sep 1.

PMID:
16945449
19.

Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status.

Barbui C, Campomori A, Mezzalira L, Lopatriello S, Cas RD, Garattini S.

Int Clin Psychopharmacol. 2001 Jul;16(4):227-33.

PMID:
11459337
20.

[Consumption of antidepressants in Chile from 1992 to 2004].

Jirón M, Machado M, Ruiz I.

Rev Med Chil. 2008 Sep;136(9):1147-54. doi: /S0034-98872008000900009. Epub 2008 Nov 12. Spanish.

Supplemental Content

Support Center